Zoetis, Inc. (ZTS)
83.82
+0.86
(+1.04%)
USD |
NYSE |
Nov 13, 16:00
83.82
0.00 (0.00%)
After-Hours: 17:25
Zoetis Market Cap : 34.16B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 33.81B |
| November 11, 2026 | 33.65B |
| November 10, 2026 | 33.60B |
| November 09, 2026 | 33.54B |
| November 06, 2026 | 32.35B |
| November 05, 2026 | 33.46B |
| November 04, 2026 | 36.35B |
| November 03, 2026 | 33.82B |
| November 02, 2026 | 34.45B |
| October 30, 2026 | 33.02B |
| October 29, 2026 | 32.64B |
| October 28, 2026 | 32.22B |
| October 27, 2026 | 32.40B |
| October 26, 2026 | 33.53B |
| October 23, 2026 | 33.56B |
| October 22, 2026 | 33.96B |
| October 21, 2026 | 32.97B |
| October 20, 2026 | 33.15B |
| October 19, 2026 | 32.96B |
| October 16, 2026 | 32.88B |
| October 15, 2026 | 32.48B |
| October 14, 2026 | 31.18B |
| October 13, 2026 | 30.77B |
| October 12, 2026 | 31.33B |
| October 09, 2026 | 30.98B |
| Date | Value |
|---|---|
| October 08, 2026 | 30.27B |
| October 07, 2026 | 29.63B |
| October 06, 2026 | 29.54B |
| October 05, 2026 | 29.57B |
| October 02, 2026 | 28.86B |
| October 01, 2026 | 28.62B |
| September 30, 2026 | 28.92B |
| September 29, 2026 | 29.12B |
| September 28, 2026 | 29.58B |
| September 25, 2026 | 29.43B |
| September 24, 2026 | 29.10B |
| September 23, 2026 | 29.66B |
| September 22, 2026 | 30.18B |
| September 21, 2026 | 29.54B |
| September 18, 2026 | 29.57B |
| September 17, 2026 | 30.24B |
| September 16, 2026 | 30.23B |
| September 15, 2026 | 30.41B |
| September 14, 2026 | 30.51B |
| September 11, 2026 | 30.22B |
| September 10, 2026 | 30.18B |
| September 09, 2026 | 30.36B |
| September 08, 2026 | 30.47B |
| September 04, 2026 | 31.40B |
| September 03, 2026 | 31.60B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 364.44B |
| Phibro Animal Health Corp. | 1.461B |
| Eli Lilly & Co. | 1.360T |
| Pfizer Inc. | 164.73B |
| Bristol Myers Squibb Co. | 129.65B |
Market Cap Related Metrics
| PE Ratio | 14.24 |
| PS Ratio | 3.725 |
| Price to Book Value | 10.34 |
| Price to Free Cash Flow | 15.55 |
| Price | 83.82 |
| Earnings Yield | 7.02% |
| Operating PE Ratio | 9.969 |
| Normalized PE Ratio | 13.36 |